Independent PR agency Chandler Chicco acquired
July 13, 2007Medical Communications, Sales and Marketing Chandler Chicco, inVentiv Health
The world’s largest private healthcare PR firm Chandler Chicco Agency has been bought out by US marketing group inVentiv Health …
Piramed and Domainex named among best of British biotech
July 12, 2007Research and Development Piramed, domainex
Piramed and Domainex are among the cutting-edge companies which have been recognised as the best of the UKs biotech sector.UK …
Janssen’s Invega approved in Europe
July 12, 2007Sales and Marketing
Janssen-Cilag's once-daily schizophrenia treatment, Invega, has been granted European approval, making it the first oral, prolonged-release drug for the condition …
NICE reverses decision on Alimta
July 11, 2007Sales and Marketing
Patients with the deadly type of lung cancer called mesothelioma will now be able to receive Lilly's Alimta after NICE …
Remote Control
July 9, 2007Business Services home working, recruitment, remote working
Vorsprung durch technik? Technological advances have allowed employees to spend increasing amounts of time working remotely away from the office. …
Latest news from Datamonitor
July 9, 2007Research and Development, Sales and Marketing
Genzyme says osteoarthritis treatment misses trial goalsGenzyme has reported that its trial of hylastan in treating pain in patients with …
ABPI launches legal challenge to prescribing controls
July 5, 2007generics
The UK pharmaceutical industry has announced plans to take legal action against the government over the way it controls how …
Surgeon appointed to lead new NHS review
July 5, 2007One of the world's leading surgeons, Professor Ara Darzi, has been handed the task of conducting a major new review …
Dementia services failing patients, says watchdog
July 5, 2007Dementia is being given far too low a priority by health and social services in the UK, despite a rapid …
Moore’s Sicko documentary launched in US
July 5, 2007Sales and Marketing EU, US, hc, reform
Michael Moore's new film about the US healthcare system, Sicko, is stirring controversy following its release in cinemas across America …
Roche launches $3 billion hostile takeover bid for diagnostics company
July 5, 2007Sales and Marketing
Roche has launched a hostile takeover bid for cancer diagnostics company Ventana, offering to pay around $3 billion for the …
Advertising world celebrates the Best of Health
July 5, 2007Medical Communications
Glitz, glamour and a certain type of buttoned-down cool came together at the annual Best of Health Awards, which this …
Onyx to promote UCB narcolepsy drug
July 3, 2007Medical Communications
Onyx Health has been appointed to promote UCB Pharma's narcolepsy treatment Xyrem in the UK.The orphan drug expanded its European …
Latest news from Datamonitor
July 2, 2007Research and Development
Biovest reports encouraging interim results for cancer vaccineBiovest International, a majority-owned subsidiary of Accentia Biopharmaceuticals, has revealed positive interim data …
Clinical Trials: The future is hub-shaped
July 2, 2007Research and Development clinical trials, design
The global clinical trials market continues to grow and is currently worth an estimated $10 billion; so much so that …
Alzheimer’s sufferers wait for judgment as NICE put in dock
June 28, 2007Sales and Marketing
Alzheimer's sufferers are just weeks away from finding out if the judicial review of NICE's decision-making will be successful.The High …
Prime Minister Brown appoints Alan Johnson Health Secretary
June 28, 2007For his first cabinet as Prime Minister Gordon Brown has appointed former education secretary Alan Johnson to head up the …
Revlimid set for UK launch
June 28, 2007Revlimid, a new oral treatment for multiple myeloma has been approved in Europe and is set for imminent launch in …
FDA approves Lyrica for chronic pain condition
June 28, 2007Sales and Marketing
Pfizer's Lyrica has become the first treatment to be approved in the US for fibromyalgia, a widespread chronic pain condition.Lyrica …
GSK’s leukaemia drug closer to European approval
June 28, 2007Sales and Marketing
GlaxoSmithKline's orphan leukaemia treatment Atriance has been recommended for European approval by a key EMEA committee.Atriance (nelarabine) was given a …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
